Literature DB >> 15236085

Effects of sevoflurane on cardiovascular dynamics, coronary circulation and myocardial metabolism in dogs.

S Akazawa1, R Shimizu, H Kasuda, K Nemoto, Y Yoshizawa, S Inoue.   

Abstract

The effects of 2.5% and 5% of sevoflurane anesthesia on hemodynamics and myocardial metabolism were studied in pentobarbital-pancuronium anesthetized dogs. The interaction between nicardipine and 2.5% sevoflurane was also examined. Sevoflurane produced dose-dependent ( P << 0.05 to P << 0.01) decreases in systolic arterial pressure (SAP), heart rate (HR), cardiac index (CI), left ventricular minute work index (LVMWI), maximum rate of rise of left ventricular pressure (LV dP/dt), the time constant of fall in isovolumic left ventricular pressure (T) and systemic vascular resistance (SVR), whereas stroke volume index (SVI) and left ventricular end-diastolic pressure (LVEDP) remained unchanged. Central venous pressure (CVP) was significantly ( P << 0.05) increased at 5%. Myocardial oxygen consumption (MV(O)(2)), and myocardial lactate extraction ratio (ML ext) were decreased in a dose-dependent manner ( P << 0.05). Myocardial oxygen extraction ratio (M(O)(2) ext) was significantly ( P << 0.01) decreased at 5%. The ratio of the left ventricular minute work index to myocardial oxygen consumption (LVMWI/MV(O)(2)), i.e., left ventricular efficiency was significantly decreased only at 5% ( P << 0.05). Coronary sinus blood flow (CSBF) was significantly ( P << 0.05) decreased only at 2.5% sevoflurane and coronary vascular resistance (CVR) was significantly ( P << 0.01) decreased only at 5% sevoflurane. The ratio of CSBF to CO (CSBF/CO) showed a tendency to increase as sevoflurane concentrations were increased. Nicardipine (0.01 mg.kg(-1)) administered intravenously under 2.5% sevoflurane caused significant ( P << 0.05 to P << 0.01) decreases in SAP, HR, LV dP/dt, SVR, and CVR, and increases in CVP, SVI, CI, and CSBF ( P << 0.05 to P << 0.01). CSBF/CO remained unchanged. MV(O)(2), M(O)(2) ext, and ML ext were significantly ( P << 0.05 to P << 0.01) decreased. LVMWI/MV(O)(2) showed a tendency to increase. It is concluded that sevoflurane causes a rapidly and easily controlled cardiovascular depression and may not have unfavorable effects on coronary circulation and myocardial metabolism. Nicardipine exerts a synergistic myocardial depressant effect on sevoflurane, in terms of both cardiovascular dynamics and myocardial metabolism.

Entities:  

Year:  1988        PMID: 15236085     DOI: 10.1007/s0054080020227

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  27 in total

1.  Hemodynamic determinants of the time-course of fall in canine left ventricular pressure.

Authors:  J L Weiss; J W Frederiksen; M L Weisfeldt
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

2.  alpha-Adrenoceptor attenuation of the coronary vascular response to severe exercise in the conscious dog.

Authors:  P A Murray; S F Vatner
Journal:  Circ Res       Date:  1979-11       Impact factor: 17.367

3.  Effects of isoflurane on the baroreceptor reflex.

Authors:  J L Seagard; E O Elegbe; F A Hopp; Z J Bosnjak; J H von Colditz; J H Kalbfleisch; J P Kampine
Journal:  Anesthesiology       Date:  1983-12       Impact factor: 7.892

4.  Isoflurane--a powerful coronary vasodilator in patients with coronary artery disease.

Authors:  S Reiz; E Bålfors; M B Sørensen; S Ariola; A Friedman; H Truedsson
Journal:  Anesthesiology       Date:  1983-08       Impact factor: 7.892

5.  Are the myocardial functional and metabolic effects of isoflurane really different from those of halothane and enflurane?

Authors:  R G Merin
Journal:  Anesthesiology       Date:  1981-10       Impact factor: 7.892

6.  Sevoflurane: a new inhalational anesthetic agent.

Authors:  R F Wallin; B M Regan; M D Napoli; I J Stern
Journal:  Anesth Analg       Date:  1975 Nov-Dec       Impact factor: 5.108

7.  Regional coronary hemodynamics during isoflurane-nitrous oxide anesthesia in patients with ischemic heart disease.

Authors:  S Reiz; M Ostman
Journal:  Anesth Analg       Date:  1985-06       Impact factor: 5.108

8.  Myocardial metabolism and hemodynamic responses with isoflurane anesthesia for coronary arterial surgery.

Authors:  E A Moffitt; R A Barker; J J Glenn; D D Imrie; C DelCampo; R W Landymore; C E Kinley; D A Murphy
Journal:  Anesth Analg       Date:  1986-01       Impact factor: 5.108

9.  Clinical characteristics and biotransformation of sevoflurane in healthy human volunteers.

Authors:  D A Holaday; F R Smith
Journal:  Anesthesiology       Date:  1981-02       Impact factor: 7.892

10.  Does renin determine the blood pressure response to calcium entry blockers?

Authors:  B Waeber; J Nussberger; H R Brunner
Journal:  Hypertension       Date:  1985 Mar-Apr       Impact factor: 10.190

View more
  9 in total

1.  Changes in circulating blood volume following isoflurane or sevoflurane anesthesia.

Authors:  H Hamada; M Takaori; K Kimura; A Fukui; Y Fujita
Journal:  J Anesth       Date:  1993-07       Impact factor: 2.078

2.  Differential vascular reactivity of canine mesenteric arteries and veins to sevoflurane.

Authors:  Kazu-Ichi Yoshida; Akiyoshi Ohsawa
Journal:  J Anesth       Date:  1998-03       Impact factor: 2.078

3.  Sevoflurane anesthesia maintains reflex tachycardia on position change from supine recumbent to head-up tilt.

Authors:  Hitoshi Adachi
Journal:  J Anesth       Date:  1996-06       Impact factor: 2.078

4.  Anesthetic potency and cardiopulmonary effects of sevoflurane in goats: comparison with isoflurane and halothane.

Authors:  Y Hikasa; K Okuyama; T Kakuta; K Takase; S Ogasawara
Journal:  Can J Vet Res       Date:  1998-10       Impact factor: 1.310

5.  Comparison of the direct effects of sevoflurane, isoflurane and halothane on isolated canine coronary arteries.

Authors:  K Nakamura; H Toda; Y Hatano; K Mori
Journal:  Can J Anaesth       Date:  1993-03       Impact factor: 5.063

6.  The echocardiographic assessment of left ventricular performance during sevoflurane and halothane anesthesia.

Authors:  H Kasuda; S Akazawa; R Shimizu
Journal:  J Anesth       Date:  1990-10       Impact factor: 2.078

7.  Effects of sevoflurane with or without nitrous oxide on cardiac contractility and sinoatrial node rate.

Authors:  M Manabe; I Ookawa; A Nonaka; T Kumazawa
Journal:  J Anesth       Date:  1989-09-01       Impact factor: 2.078

8.  Exploring kinetic energy as a new marker of cardiac function in the single ventricle circulation.

Authors:  James Wong; Radomir Chabiniok; Shane M Tibby; Kuberan Pushparajah; Eva Sammut; David Celermajer; Daniel Giese; Tarique Hussain; Gerald F Greil; Tobias Schaeffter; Reza Razavi
Journal:  J Appl Physiol (1985)       Date:  2018-01-25

9.  Pressure-volume loop-derived cardiac indices during dobutamine stress: a step towards understanding limitations in cardiac output in children with hypoplastic left heart syndrome.

Authors:  James Wong; Kuberan Pushparajah; Adelaide de Vecchi; Bram Ruijsink; Gerald F Greil; Tarique Hussain; Reza Razavi
Journal:  Int J Cardiol       Date:  2016-12-22       Impact factor: 4.164

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.